Why should you subscribe to the OracleBio newsletter?

  • Cutting-Edge Insights: Stay informed with the latest advancements and trends in Digital Pathology, helping you make informed decisions and stay ahead in R&D.
  • Expert Analysis: Gain access to expert analysis and interpretations of complex image data, enhancing your understanding of cellular phenotyping and its applications in personalized medicine.
  • Company News & Service Updates: Interested in what we do? Follow our journey as the leaders within our field, be the first to hear about our growth plans, latest service offerings, and much more.



By subscribing, you are consenting to OracleBio processing your data. For more information about the processing of your personal information and your rights, please review our Privacy Policy.

You may also be interested in these Blogs & Insights:

OracleBio’s green journey so far – Our road to sustainability

OracleBio’s green journey so far – Our road to sustainability

As a Glasgow-born company, we're immensely proud to see COP26 being hosted in our home city. With the Climate Change Conference in mind, it's a good time for us to reflect on our own actions and how we're helping tackle climate change as a company and as individuals....

Digital Pathology Today Podcast with John Waller

Digital Pathology Today Podcast with John Waller

In this podcast, our Chief Operations Officer & founder, John Waller, was invited onto the hugely popular Digital Pathology Today podcast. John and the podcast host, Dr. Joseph Anderson, chat about OracleBio’s humble beginnings and our quantitative digital...

OracleBio and the INCISE collaboration project

OracleBio and the INCISE collaboration project

Bowel cancer is currently the second most deadly cancer in the UK, accounting for 10% of all cancer deaths. The current screening protocol for this type of malignancy involves a colonoscopy for patients who test positive for blood in their stool. About one in three of...